- Home Page
- EMVDA
- EURHAVAC
- Malaria - The Disease
- Press Releases
- EMVI Statutes
- Board Members and Scientific Advisory Committee Members
- Memoranda of Understanding and Intent
- EMVI Strategy
- Project Portfolio
- Annual Reports
- The Donors
- Mid-Term Review 2005
- Directives - Guidelines - Regulations
- Meeting Reports
- Procedures
- Calls
- Vacancies
EMVI Board Members
Hannah Akuffo, Chairperson, Sweden
Joe Cohen, GlaxoSmithKline Biologicals, Belgium
Kirsten Havemann, Denmark (observer status)
Wen Kilama, AMANET, Tanzania
Diarmuid O'Donovan, Vice Chairperson, Republic of Ireland
Nils Strandberg Pedersen, Statens Serum Institut, Contracting Institution, Denmark
Charles De Taisne, Sanofi Pasteur, France
Pierre Meulien, SAC Chairperson, Republic of Ireland (non-voting)
An observer, EC
EMVI Scientific Advisory Committee (SAC) Members
2003 (March)Pierre Meulien, Chairperson, Canada (Vaccine Research and Development)
2004 (March) Marita Troye Blomberg, Sweden (Immunological Assays and Parasitology)
2006 (April) Marie-Paule Kieny, Switzerland (Infectious Diseases and Biological Technology)
2004 (March) Peter Kremsner, Germany (Clinical Epidemiology and Clinical Trials)
2007 (January) Samuel McConkey, Republic of Ireland (Tropical Diseases and Clinical Trials)
2008 (January) Alister Craig (Molecular Biology of Malaria)
2007 (June) Aissatou Toure, Senegal (Malaria, Epidemiology, Immunology, Ethics)